Delta 9 Cannabis Inc.

DN

CA2477541049

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 03:19:47 2024-04-18 pm EDT			5-day change	1st Jan Change
0.025 ^CAD	0.00%		-28.57%	0.00%

Apr. 01	Delta 9 Cannabis to Seek Cannabis Stores Acquisition	CI
Apr. 01	Transcript : Delta 9 Cannabis Inc., 2023 Earnings Call, Apr 01, 2024

Delta 9 Cannabis Inc.'s Equity Buyback announced on October 20, 2020, has expired.

October 24, 2021

The company expired its plan on October 25, 2021.

Latest news about Delta 9 Cannabis Inc.

Delta 9 Cannabis to Seek Cannabis Stores Acquisition	Apr. 01	CI
Transcript : Delta 9 Cannabis Inc., 2023 Earnings Call, Apr 01, 2024	Apr. 01
Delta 9 Cannabis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Delta 9 Cannabis Inc. to Supply Bulk Cannabis to Leading Canadian Licensed Producer	Jan. 23	CI
Transcript : Delta 9 Cannabis Inc., Q3 2023 Earnings Call, Nov 15, 2023	Nov. 15
Delta 9 Cannabis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Delta 9 Cannabis Inc. to Supply Cannabis to New Brunswick	23-10-30	CI
Delta 9 Cannabis Inc. announced that it has received $0.05 million in funding from Haywood Securities Inc.	23-08-29	CI
Transcript : Delta 9 Cannabis Inc., Q2 2023 Earnings Call, Aug 15, 2023	23-08-15
Delta 9 Cannabis Reported Financials for Q2 2023	23-08-15	MT
North American Morning Briefing : China Angst -2-	23-08-15	DJ
Delta 9 Cannabis Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Delta 9 Cannabis to Supply Cannabis to Northwest Territories	23-08-10	MT
Delta 9 Cannabis Inc. to Supply Cannabis to Northwest Territories	23-08-09	CI
Delta 9 Cannabis Expanding Distribution Business In Manitoba	23-08-03	MT
Delta 9 Cannabis Provides Revenue Outlook for Q2	23-07-27	MT
Delta 9 Cannabis Secures Grow Pod Contract for Cultivation Facility in British Columbia	23-06-14	MT
Delta 9 Cannabis Inc. Secures A Purchase Order for Grow Pods for Cultivation Facility in British Columbia	23-06-13	CI
Delta 9 Cannabis On Manitoba Government's Bill 10 Amendment to Repeal 6% Social Responsibility Fee	23-05-18	MT
Transcript : Delta 9 Cannabis Inc., Q1 2023 Earnings Call, May 16, 2023	23-05-16
Delta 9 Cannabis' Q1 Loss Narrows, Revenue Rises	23-05-16	MT
North American Morning Briefing : Retail Sales, -2-	23-05-16	DJ
Delta 9 Cannabis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Delta 9 Cannabis Provides Guidance for Q1 2023 Results	23-05-09	MT
Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three Month Period Ending March 31, 2023	23-05-08	CI

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.025 CAD

Average target price

0.06 CAD

Spread / Average Target

+140.00%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DELTA 9 CANNABIS INC.	0.00%	4.95M
ELI LILLY AND COMPANY	+27.97%	676B
NOVO NORDISK A/S	+23.58%	554B
JOHNSON & JOHNSON	-7.02%	349B
MERCK & CO., INC.	+14.85%	318B
ABBVIE INC.	+6.25%	291B
ASTRAZENECA PLC	+2.96%	210B
NOVARTIS AG	-0.41%	204B
ROCHE HOLDING AG	-10.02%	194B
PFIZER, INC.	-11.81%	144B

Other Pharmaceuticals